APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Duck Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Duck Vaccines Industry Growth and Trends Forecast to 2032

Report ID 173986940122 December 2025105 pages

Choose your research edition.

Industry ResearchDuck Vaccines Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Duck Vaccines Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Duck Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Duck Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Duck Vaccines Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Duck Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Duck Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Duck Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Duck Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Duck Vaccines include CAHIC, Zoetis, Merck Animal Health, Yebio, Vaksindo, Ringpu Biology, Harbin Veterinary Research Institute, FATRO and Elanco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Duck Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Duck Vaccines market size, estimates, and forecasts are presented in terms of sales volume (m units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Duck Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Duck Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Duck Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Duck Vaccines Market by Company

CAHIC

Zoetis

Merck Animal Health

Yebio

Vaksindo

Ringpu Biology

Harbin Veterinary Research Institute

FATRO

Elanco

CEVA

CAVAC

Boehringer Ingelheim

Duck Vaccines Segment by Type

Attenuated Live Vaccines

Killed Vaccines

Duck Vaccines Segment by Application

Avian Influenza Vaccine

Newcastle Disease Vaccine

Other

Duck Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Duck Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Duck Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Duck Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Duck Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Duck Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Attenuated Live Vaccines Table 2. Major Company of Killed Vaccines Table 3. Global Duck Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Duck Vaccines Sales by Type (2021-2026) & (m units) Table 5. Global Duck Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Duck Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Duck Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Duck Vaccines Price by Type (2021-2026) & (US$/k unit) Table 9. Global Duck Vaccines Sales by Type (2027-2032) & (m units) Table 10. Global Duck Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Duck Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Duck Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Duck Vaccines Price by Type (2027-2032) & (US$/k unit) Table 14. North America Duck Vaccines Sales by Type (2021-2026) & (m units) Table 15. North America Duck Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Duck Vaccines Sales by Type (2021-2026) & (m units) Table 17. Europe Duck Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Duck Vaccines Sales by Type (2021-2026) & (m units) Table 19. Asia-Pacific Duck Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Duck Vaccines Sales by Type (2021-2026) & (m units) Table 21. Latin America Duck Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Duck Vaccines Sales by Type (2021-2026) & (m units) Table 23. Middle East and Africa Duck Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Duck Vaccines Industry Trends Table 25. Duck Vaccines Industry Drivers Table 26. Duck Vaccines Industry Opportunities and Challenges Table 27. Duck Vaccines Industry Restraints Table 28. Global Duck Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Duck Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Duck Vaccines Sales by Company (2021-2026) & (m units) Table 31. Global Duck Vaccines Sales Share by Company (2021-2026) Table 32. Global Duck Vaccines Market Price by Company (2021-2026) & (US$/k unit) Table 33. Global Duck Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Duck Vaccines Major Company Production Sites and Headquarters Table 35. Global Duck Vaccines Company, Product Type & Application Table 36. Global Duck Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Duck Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Duck Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Duck Vaccines Sales by Region (2021-2026) & (m units) Table 41. Global Duck Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Duck Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Duck Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Duck Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 45. Global Duck Vaccines Sales by Region (2027-2032) & (m units) Table 46. Global Duck Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Duck Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Duck Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Duck Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2027-2032) Table 50. Global Duck Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Duck Vaccines Sales by Application (2021-2026) & (m units) Table 52. Global Duck Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Duck Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Duck Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Duck Vaccines Price by Application (2021-2026) & (US$/k unit) Table 56. Global Duck Vaccines Sales by Application (2027-2032) & (m units) Table 57. Global Duck Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Duck Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Duck Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Duck Vaccines Price by Application (2027-2032) & (US$/k unit) Table 61. North America Duck Vaccines Sales by Application (2021-2026) & (m units) Table 62. North America Duck Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Duck Vaccines Sales by Application (2021-2026) & (m units) Table 64. Europe Duck Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Duck Vaccines Sales by Application (2021-2026) & (m units) Table 66. Asia-Pacific Duck Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Duck Vaccines Sales by Application (2021-2026) & (m units) Table 68. Latin America Duck Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Duck Vaccines Sales by Application (2021-2026) & (m units) Table 70. Middle East and Africa Duck Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. CAHIC Company Information Table 72. CAHIC Business Overview Table 73. CAHIC Duck Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 74. CAHIC Duck Vaccines Product Portfolio Table 75. CAHIC Recent Development Table 76. Zoetis Company Information Table 77. Zoetis Business Overview Table 78. Zoetis Duck Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 79. Zoetis Duck Vaccines Product Portfolio Table 80. Zoetis Recent Development Table 81. Merck Animal Health Company Information Table 82. Merck Animal Health Business Overview Table 83. Merck Animal Health Duck Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 84. Merck Animal Health Duck Vaccines Product Portfolio Table 85. Merck Animal Health Recent Development Table 86. Yebio Company Information Table 87. Yebio Business Overview Table 88. Yebio Duck Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 89. Yebio Duck Vaccines Product Portfolio Table 90. Yebio Recent Development Table 91. Vaksindo Company Information Table 92. Vaksindo Business Overview Table 93. Vaksindo Duck Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 94. Vaksindo Duck Vaccines Product Portfolio Table 95. Vaksindo Recent Development Table 96. Ringpu Biology Company Information Table 97. Ringpu Biology Business Overview Table 98. Ringpu Biology Duck Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 99. Ringpu Biology Duck Vaccines Product Portfolio Table 100. Ringpu Biology Recent Development Table 101. Harbin Veterinary Research Institute Company Information Table 102. Harbin Veterinary Research Institute Business Overview Table 103. Harbin Veterinary Research Institute Duck Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 104. Harbin Veterinary Research Institute Duck Vaccines Product Portfolio Table 105. Harbin Veterinary Research Institute Recent Development Table 106. FATRO Company Information Table 107. FATRO Business Overview Table 108. FATRO Duck Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 109. FATRO Duck Vaccines Product Portfolio Table 110. FATRO Recent Development Table 111. Elanco Company Information Table 112. Elanco Business Overview Table 113. Elanco Duck Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 114. Elanco Duck Vaccines Product Portfolio Table 115. Elanco Recent Development Table 116. CEVA Company Information Table 117. CEVA Business Overview Table 118. CEVA Duck Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 119. CEVA Duck Vaccines Product Portfolio Table 120. CEVA Recent Development Table 121. CAVAC Company Information Table 122. CAVAC Business Overview Table 123. CAVAC Duck Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 124. CAVAC Duck Vaccines Product Portfolio Table 125. CAVAC Recent Development Table 126. Boehringer Ingelheim Company Information Table 127. Boehringer Ingelheim Business Overview Table 128. Boehringer Ingelheim Duck Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 129. Boehringer Ingelheim Duck Vaccines Product Portfolio Table 130. Boehringer Ingelheim Recent Development Table 131. North America Duck Vaccines Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 132. North America Duck Vaccines Sales by Country (2021-2026) & (m units) Table 133. North America Duck Vaccines Sales Market Share by Country (2021-2026) Table 134. North America Duck Vaccines Sales Forecast by Country (2027-2032) & (m units) Table 135. North America Duck Vaccines Sales Market Share Forecast by Country (2027-2032) Table 136. North America Duck Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Duck Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Duck Vaccines Market Share by Country (2021-2026) Table 139. North America Duck Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Duck Vaccines Market Share Forecast by Country (2027-2032) Table 141. Europe Duck Vaccines Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 142. Europe Duck Vaccines Sales by Country (2021-2026) & (m units) Table 143. Europe Duck Vaccines Sales Market Share by Country (2021-2026) Table 144. Europe Duck Vaccines Sales Forecast by Country (2027-2032) & (m units) Table 145. Europe Duck Vaccines Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Duck Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Duck Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Duck Vaccines Market Share by Country (2021-2026) Table 149. Europe Duck Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Duck Vaccines Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Duck Vaccines Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Duck Vaccines Sales by Country (2021-2026) & (m units) Table 153. Asia-Pacific Duck Vaccines Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Duck Vaccines Sales Forecast by Country (2027-2032) & (m units) Table 155. Asia-Pacific Duck Vaccines Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Duck Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Duck Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Duck Vaccines Market Share by Country (2021-2026) Table 159. Asia-Pacific Duck Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Duck Vaccines Market Share Forecast by Country (2027-2032) Table 161. Latin America Duck Vaccines Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 162. Latin America Duck Vaccines Sales by Country (2021-2026) & (m units) Table 163. Latin America Duck Vaccines Sales Market Share by Country (2021-2026) Table 164. Latin America Duck Vaccines Sales Forecast by Country (2027-2032) & (m units) Table 165. Latin America Duck Vaccines Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Duck Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Duck Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Duck Vaccines Market Share by Country (2021-2026) Table 169. Latin America Duck Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Duck Vaccines Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Duck Vaccines Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Duck Vaccines Sales by Country (2021-2026) & (m units) Table 173. Middle East and Africa Duck Vaccines Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Duck Vaccines Sales Forecast by Country (2027-2032) & (m units) Table 175. Middle East and Africa Duck Vaccines Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Duck Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Duck Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Duck Vaccines Market Share by Country (2021-2026) Table 179. Middle East and Africa Duck Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Duck Vaccines Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Duck Vaccines Distributors List Table 184. Duck Vaccines Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Duck Vaccines Image Figure 2. Global Duck Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Duck Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Duck Vaccines Sales (2021-2032) & (m units) Figure 5. Attenuated Live Vaccines Image Figure 6. Global Attenuated Live Vaccines Sales YoY Growth (2021-2032) & (m units) Figure 7. Killed Vaccines Image Figure 8. Global Killed Vaccines Sales YoY Growth (2021-2032) & (m units) Figure 9. Global Duck Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Duck Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Duck Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Duck Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Duck Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Duck Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Duck Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Duck Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Duck Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Duck Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Duck Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Duck Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Duck Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Avian Influenza Vaccine Image Figure 24. Global Avian Influenza Vaccine Sales YoY Growth (2021-2032) & (m units) Figure 25. Newcastle Disease Vaccine Image Figure 26. Global Newcastle Disease Vaccine Sales YoY Growth (2021-2032) & (m units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (m units) Figure 29. Global Duck Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Duck Vaccines Market Share by Application 2025 VS 2032 Figure 31. North America Duck Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. North America Duck Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Europe Duck Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Europe Duck Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Duck Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Duck Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Latin America Duck Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Duck Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Duck Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Duck Vaccines Sales Market Share in Value by Application in 2025 Figure 41. North America Duck Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 42. North America Duck Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Duck Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Duck Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Duck Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 46. Europe Duck Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Duck Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Duck Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Duck Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 50. Asia-Pacific Duck Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Duck Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Duck Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Duck Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 54. Latin America Duck Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Duck Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Duck Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Duck Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 58. Middle East and Africa Duck Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Duck Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Duck Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Duck Vaccines Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Duck Vaccines Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Attenuated Live Vaccines
  • Killed Vaccines
Applications
  • Avian Influenza Vaccine
  • Newcastle Disease Vaccine
  • Other
Companies covered
  • CAHIC
  • Zoetis
  • Merck Animal Health
  • Yebio
  • Vaksindo
  • Ringpu Biology
  • Harbin Veterinary Research Institute
  • FATRO
  • Elanco
  • CEVA
  • CAVAC
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Duck Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Duck Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Duck Vaccines Market by Type
  6. 1.3.1 Attenuated Live Vaccines
  7. 1.3.2 Killed Vaccines
  8. 1.4 Global Duck Vaccines Market Size by Type
  9. 1.4.1 Global Duck Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Duck Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Duck Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Duck Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Duck Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Duck Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Duck Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Duck Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Duck Vaccines Industry Trends
  2. 2.2 Duck Vaccines Industry Drivers
  3. 2.3 Duck Vaccines Industry Opportunities and Challenges
  4. 2.4 Duck Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Duck Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Duck Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Duck Vaccines Price (2021-2026)
  4. 3.4 Global Duck Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Duck Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Duck Vaccines Company, Product Type & Application
  7. 3.7 Global Duck Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Duck Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Duck Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Duck Vaccines Tier 1, Tier 2, and Tier 3
4 Duck Vaccines Regional Status and Outlook
  1. 4.1 Global Duck Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Duck Vaccines Historic Market Size by Region
  3. 4.2.1 Global Duck Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Duck Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Duck Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Duck Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Duck Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Duck Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Duck Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Duck Vaccines by Application
  1. 5.1 Duck Vaccines Market by Application
  2. 5.1.1 Avian Influenza Vaccine
  3. 5.1.2 Newcastle Disease Vaccine
  4. 5.1.3 Other
  5. 5.2 Global Duck Vaccines Market Size by Application
  6. 5.2.1 Global Duck Vaccines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Duck Vaccines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Duck Vaccines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Duck Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Duck Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Duck Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Duck Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Duck Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CAHIC
  2. 6.1.1 CAHIC Company Information
  3. 6.1.2 CAHIC Business Overview
  4. 6.1.3 CAHIC Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CAHIC Duck Vaccines Product Portfolio
  6. 6.1.5 CAHIC Recent Developments
  7. 6.2 Zoetis
  8. 6.2.1 Zoetis Company Information
  9. 6.2.2 Zoetis Business Overview
  10. 6.2.3 Zoetis Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zoetis Duck Vaccines Product Portfolio
  12. 6.2.5 Zoetis Recent Developments
  13. 6.3 Merck Animal Health
  14. 6.3.1 Merck Animal Health Company Information
  15. 6.3.2 Merck Animal Health Business Overview
  16. 6.3.3 Merck Animal Health Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Animal Health Duck Vaccines Product Portfolio
  18. 6.3.5 Merck Animal Health Recent Developments
  19. 6.4 Yebio
  20. 6.4.1 Yebio Company Information
  21. 6.4.2 Yebio Business Overview
  22. 6.4.3 Yebio Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Yebio Duck Vaccines Product Portfolio
  24. 6.4.5 Yebio Recent Developments
  25. 6.5 Vaksindo
  26. 6.5.1 Vaksindo Company Information
  27. 6.5.2 Vaksindo Business Overview
  28. 6.5.3 Vaksindo Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Vaksindo Duck Vaccines Product Portfolio
  30. 6.5.5 Vaksindo Recent Developments
  31. 6.6 Ringpu Biology
  32. 6.6.1 Ringpu Biology Company Information
  33. 6.6.2 Ringpu Biology Business Overview
  34. 6.6.3 Ringpu Biology Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ringpu Biology Duck Vaccines Product Portfolio
  36. 6.6.5 Ringpu Biology Recent Developments
  37. 6.7 Harbin Veterinary Research Institute
  38. 6.7.1 Harbin Veterinary Research Institute Company Information
  39. 6.7.2 Harbin Veterinary Research Institute Business Overview
  40. 6.7.3 Harbin Veterinary Research Institute Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Harbin Veterinary Research Institute Duck Vaccines Product Portfolio
  42. 6.7.5 Harbin Veterinary Research Institute Recent Developments
  43. 6.8 FATRO
  44. 6.8.1 FATRO Company Information
  45. 6.8.2 FATRO Business Overview
  46. 6.8.3 FATRO Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 FATRO Duck Vaccines Product Portfolio
  48. 6.8.5 FATRO Recent Developments
  49. 6.9 Elanco
  50. 6.9.1 Elanco Company Information
  51. 6.9.2 Elanco Business Overview
  52. 6.9.3 Elanco Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Elanco Duck Vaccines Product Portfolio
  54. 6.9.5 Elanco Recent Developments
  55. 6.10 CEVA
  56. 6.10.1 CEVA Company Information
  57. 6.10.2 CEVA Business Overview
  58. 6.10.3 CEVA Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CEVA Duck Vaccines Product Portfolio
  60. 6.10.5 CEVA Recent Developments
  61. 6.11 CAVAC
  62. 6.11.1 CAVAC Company Information
  63. 6.11.2 CAVAC Business Overview
  64. 6.11.3 CAVAC Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CAVAC Duck Vaccines Product Portfolio
  66. 6.11.5 CAVAC Recent Developments
  67. 6.12 Boehringer Ingelheim
  68. 6.12.1 Boehringer Ingelheim Company Information
  69. 6.12.2 Boehringer Ingelheim Business Overview
  70. 6.12.3 Boehringer Ingelheim Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Boehringer Ingelheim Duck Vaccines Product Portfolio
  72. 6.12.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Duck Vaccines Sales by Country
  2. 7.1.1 North America Duck Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Duck Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Duck Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Duck Vaccines Market Size by Country
  6. 7.2.1 North America Duck Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Duck Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Duck Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Duck Vaccines Sales by Country
  2. 8.1.1 Europe Duck Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Duck Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Duck Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Duck Vaccines Market Size by Country
  6. 8.2.1 Europe Duck Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Duck Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Duck Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Duck Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Duck Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Duck Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Duck Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Duck Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Duck Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Duck Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Duck Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Duck Vaccines Sales by Country
  2. 10.1.1 South America Duck Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Duck Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Duck Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Duck Vaccines Market Size by Country
  6. 10.2.1 South America Duck Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Duck Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Duck Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Duck Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Duck Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Duck Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Duck Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Duck Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Duck Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Duck Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Duck Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Duck Vaccines Value Chain Analysis
  2. 12.1.1 Duck Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Duck Vaccines Production Mode & Process
  7. 12.2 Duck Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Duck Vaccines Distributors
  10. 12.2.3 Duck Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst